SHEODESSA LTD
Company number 13052255 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
SHEODESSA LTD - Analysis Report
Company Number: 13052255
Analysis Date: 2025-07-20 12:52 UTC
Financial Health Assessment for SHEODESSA LTD as of 30 November 2024
1. Financial Health Score: C
Explanation:
SHEODESSA LTD shows clear signs of recovery after several years of financial strain, moving from negative net assets to positive territory in the latest financial year. However, the company’s margin for error remains thin with current liabilities nearly matching current assets, and a very modest net asset base. This places the company in a cautious but improving position, meriting a grade C (fair health, recovering but fragile).
2. Key Vital Signs
| Metric | 2024 Value | Interpretation |
|---|---|---|
| Fixed Assets | £2,272 | Small investment in long-term assets, typical for micro businesses. |
| Current Assets | £47,329 | Healthy level of liquid and short-term assets. |
| Current Liabilities | £45,332 | Current debts almost equal to current assets, indicating tight liquidity. |
| Net Current Assets | £1,997 | Slight positive working capital, signaling a small buffer to cover short-term debts. |
| Net Assets (Shareholders Funds) | £4,269 | Positive net worth, improved from prior negative position, indicating a return to solvency. |
| Share Capital | £1.00 | Minimal share capital, common for start-ups or micro entities. |
| Employee Count | 0 | No employees, implying reliance on owner/director or outsourced services. |
What these vital signs indicate:
- The company has moved from a state of "financial distress" — akin to a patient recovering from a critical illness — to a more stable, though still fragile, condition.
- The small but positive working capital suggests the company can meet immediate obligations without stress, but the margin is narrow (like a heartbeat just above the danger zone).
- The net asset improvement from negative £1,006 in 2023 to positive £4,269 in 2024 is a promising sign of "healing" equity and financial stability.
- The lack of employees means fixed overheads are likely low, reducing immediate financial pressures but potentially limiting growth capacity.
3. Diagnosis
Underlying Financial Condition:
- The company experienced several years of "symptoms of distress," reflected in negative net assets and negative working capital from 2020 through 2023. This suggested that liabilities exceeded assets, signaling insolvency risk.
- In the latest financial year, SHEODESSA LTD has shown a "recovery" by restoring positive net assets and working capital. This indicates improved cash management, possibly better sales or reduced liabilities.
- The balance sheet remains "thin," with current liabilities nearly matching current assets, which means the company remains vulnerable to sudden cash flow shocks or unexpected expenses.
- The business operates in the retail sale via mail order or internet sector (SIC 47910), which can have variable cash flow depending on market conditions, seasonality, or consumer demand.
- The micro entity status suggests minimal filing requirements and a lean operation, but also likely limited financial resources and buffer against downturns.
Summary Diagnosis:
SHEODESSA LTD is currently in a "stable but cautious" state of financial health. The company has overcome previous financial stress and is now solvent, but its liquidity position is tight. It is akin to a patient who has recovered from illness but must maintain a strict regimen to avoid relapse.
4. Recommendations
To strengthen financial wellness and ensure sustainable growth, the following steps are advised:
Enhance Liquidity Buffer:
Increase cash reserves or reduce short-term liabilities to expand the net current assets margin. This reduces risk of cash flow crises.Monitor Cash Flow Diligently:
Implement regular cash flow forecasting to anticipate and manage peaks and troughs in working capital needs.Consider Capital Injection:
Although share capital is minimal (£1), raising additional equity or shareholder loans could provide a financial cushion.Cost Control:
Maintain strict control over expenses, particularly variable costs linked to sales, to preserve margins.Revenue Growth Initiatives:
Focus on marketing and sales strategies to boost turnover, especially online, to increase current assets sustainably.Prepare for Seasonality:
Given the retail nature, anticipate seasonal fluctuations and plan working capital accordingly.Regular Financial Reviews:
Conduct quarterly financial health checks to detect any early "symptoms" of distress and respond promptly.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.